34 companies

Novartis

Market Cap: CHF 184.2b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

NOVN

CHF 94.03

7D

1.4%

1Y

0.9%

Merck

Market Cap: US$191.8b

Operates as a healthcare company worldwide.

MRK

US$76.84

7D

-1.0%

1Y

-38.8%

Waters

Market Cap: US$21.1b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

WAT

US$349.24

7D

0.8%

1Y

13.1%

Exelixis

Market Cap: US$11.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$43.04

7D

1.5%

1Y

98.4%

Orion Oyj

Market Cap: €8.4b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€59.75

7D

2.2%

1Y

59.4%

Abbott India

Market Cap: ₹647.1b

Operates as a pharmaceutical company in India.

500488

₹30,453.15

7D

-1.2%

1Y

17.7%

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹558.2b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

500660

₹3,295.00

7D

9.0%

1Y

25.3%

SK Biopharmaceuticals

Market Cap: ₩7.3t

A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.

A326030

₩93,000.00

7D

3.6%

1Y

8.9%

Xiamen Amoytop Biotech

Market Cap: CN¥31.4b

Engages in research, development, production, and sale of recombinant protein drugs in China.

688278

CN¥77.25

7D

3.6%

1Y

41.4%

Agios Pharmaceuticals

Market Cap: US$1.9b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

AGIO

US$32.09

7D

7.7%

1Y

-11.7%

BioArctic

Market Cap: SEK 16.1b

Develops biological drugs for patients with central nervous system disorders in Sweden.

BIOA B

SEK 181.90

7D

1.1%

1Y

-25.0%

Sanofi India

Market Cap: ₹143.0b

Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.

500674

₹6,208.95

7D

-0.9%

1Y

-28.1%

Procter & Gamble Health

Market Cap: ₹95.9b

Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.

500126

₹5,775.85

7D

6.8%

1Y

22.4%

Neuren Pharmaceuticals

Market Cap: AU$1.7b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$13.88

7D

7.8%

1Y

-35.9%

Philogen

Market Cap: €902.5m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases.

PHIL

€22.40

7D

0%

1Y

5.7%

Jeena Sikho Lifecare

Market Cap: ₹53.0b

Trades in ayurvedic medicines in India.

JSLL

₹2,132.25

7D

0.4%

1Y

96.3%

L&C BIOLTD

Market Cap: ₩653.6b

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

A290650

₩28,200.00

7D

-7.8%

1Y

49.2%

Ever Supreme Bio Technology

Market Cap: NT$13.6b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

6712

NT$171.00

7D

-0.3%

1Y

-12.3%

PharmaEngine

Market Cap: NT$13.0b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

4162

NT$90.30

7D

-2.3%

1Y

-0.3%

RPG Life Sciences

Market Cap: ₹36.1b

An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.

RPGLIFE

₹2,181.20

7D

-0.3%

1Y

52.7%

Puma Biotechnology

Market Cap: US$167.8m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

PBYI

US$3.28

7D

1.4%

1Y

-14.8%

MPH Health Care

Market Cap: €92.0m

An investment company, engages in the healthcare business in Germany.

93M1

€21.50

7D

-15.4%

1Y

-36.4%

NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag

Market Cap: Ft36.5b

Manufactures and sells pharmaceutical products in Hungary.

NATURLAND

Ft2,640.00

7D

2.3%

1Y

9.1%

JW Shinyak

Market Cap: ₩91.3b

Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.

A067290

₩1,715.00

7D

10.6%

1Y

3.3%

Ind-Swift Laboratories

Market Cap: ₹4.8b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.

INDSWFTLAB

₹81.18

7D

12.4%

1Y

-22.4%

EZZ Life Science Holdings

Market Cap: AU$73.8m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.

EZZ

AU$1.57

7D

4.0%

1Y

46.9%

Alexandria For Pharmaceuticals & Chemical Industries

Market Cap: ج.م2.2b

Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.

AXPH

ج.م431.20

7D

2.2%

1Y

97.1%

Pharmedic Pharmaceutical Medicinal

Market Cap: ₫1.0t

Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.

PMC

₫112,000.00

7D

0%

1Y

28.7%

China SXT Pharmaceuticals

Market Cap: US$22.3m

A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.

SXTC

US$1.39

7D

-10.3%

1Y

-83.5%

Arab Drug

Market Cap: ج.م1.0b

Engages in the manufacture and sale of pharmaceutical products.

New

ADCI

ج.م171.93

7D

-1.6%

1Y

82.5%

Celemics

Market Cap: ₩27.5b

Designs, manufactures, and distributes sequencing kits in South Korea.

A331920

₩3,370.00

7D

6.5%

1Y

-11.4%

Genesis IBRC India

Market Cap: ₹250.3m

Does not have significant operations.

New

514336

₹19.25

7D

0%

1Y

n/a

Scinai Immunotherapeutics

Market Cap: US$2.5m

A development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel.

SCNI

US$2.72

7D

-1.4%

1Y

-27.5%

Captor Capital

Market Cap: CA$1.5m

Engages in the retail sale of cannabis products in the United States.

CPTR

CA$0.45

7D

0%

1Y

-25.8%